BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15946501)

  • 1. [Expression of cell cycle control genes in myelodysplastic syndromes].
    Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Cao YR; Wang XL; Tu MF
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):10-4. PubMed ID: 15946501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
    Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
    Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
    Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle and apoptosis regulatory gene expression in the bone marrow of patients with de novo myelodysplastic syndromes (MDS).
    Economopoulou C; Pappa V; Papageorgiou S; Kontsioti F; Economopoulou P; Charitidou E; Girkas K; Kapsimali V; Papasteriadi C; Tsirigotis P; Papageorgiou E; Dervenoulas J; Economopoulos T
    Ann Hematol; 2010 Apr; 89(4):349-58. PubMed ID: 19813013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of p21(CIP 1), p27(KIP 1) and p 57(KIP 2) methylation in MDS and AML.
    Brakensiek K; Länger F; Kreipe H; Lehmann U
    Leuk Res; 2005 Nov; 29(11):1357-60. PubMed ID: 15936816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukemia and links to patient outcome.
    Ekberg J; Holm C; Jalili S; Richter J; Anagnostaki L; Landberg G; Persson JL
    Eur J Haematol; 2005 Aug; 75(2):106-15. PubMed ID: 16004607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes.
    Kurata M; Hasegawa M; Nakagawa Y; Abe S; Yamamoto K; Suzuki K; Kitagawa M
    Exp Mol Pathol; 2006 Dec; 81(3):249-54. PubMed ID: 16566920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia.
    Xu K; Wang L; Hao Y; Shao Z; Meng Q; Li K; Chao H; Tang K; Wang L
    Chin Med J (Engl); 1999 Dec; 112(12):1112-8. PubMed ID: 11721451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome.
    Qian J; Chen Z; Wang W; Cen J; Xue Y
    Oncol Rep; 2005 Nov; 14(5):1189-97. PubMed ID: 16211284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
    Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
    Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
    Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
    Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the expression and function of c-kit receptor on the bone marrow mononuclear cells of the patients with myelodysplastic syndromes].
    Zhang H; Shao Z; Chen G; Wang L; Zhang Y; Li K; Li L; Sun J; Hao Y
    Zhonghua Xue Ye Xue Za Zhi; 2000 Apr; 21(4):176-8. PubMed ID: 11876975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
    Zhang F; Hao Y; Pang W
    Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear phospholipase C beta1, regulation of the cell cycle and progression of acute myeloid leukemia.
    Cocco L; Manzoli L; Palka G; Martelli AM
    Adv Enzyme Regul; 2005; 45():126-35. PubMed ID: 16024064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical significance of cyclin B1 expression in adult acute leukemia patients].
    Ma WD; Xu SR; Guo XN; Jia JS; Xue F
    Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):523-6. PubMed ID: 14690581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows.
    Mundle SD; Mativi BY; Bagai K; Feldman G; Cheema P; Gautam U; Reza S; Cartlidge JD; Venugopal P; Shetty V; Gregory SA; Robin E; Rifkin S; Shah R; Raza A
    Int J Hematol; 1999 Aug; 70(2):83-90. PubMed ID: 10497846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of c-kit receptor in bone marrow mononuclear cells of patients with myelodysplastic syndromes.
    Shao Z; Zhang H; Chen G; Wang L; Li K; Zhang Y; Li L; Sun J
    Chin Med J (Engl); 2001 May; 114(5):481-5. PubMed ID: 11780408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
    Papageorgiou SG; Pappa V; Papageorgiou E; Tsirigotis P; Kontsioti F; Panani A; Dervenoulas J; Economopoulos T
    Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.